Cleared Traditional

K993643 - NEXSYSTEM AMBULATORY PATIENT MONITOR MODEL NEX 100

K993643 is an FDA 510(k) clearance for NEXSYSTEM AMBULATORY PATIENT MONITOR MO..., manufactured by Nexan Telemed , Ltd.. The device is a Class 2 Cardiovascular device with product code MWJ cleared through the Traditional 510(k) pathway after a 61-day FDA review.

K993643 · Nexan Telemed , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1999
Decision
61d
Days
Class 2
Risk

K993643 is an FDA 510(k) clearance for the NEXSYSTEM AMBULATORY PATIENT MONITOR MODEL NEX 100. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by Nexan Telemed , Ltd. (Rockville, US). The FDA issued a Cleared decision on December 28, 1999 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nexan Telemed , Ltd. devices

FDA 510(k) Submission Details - K993643

510(k) Number K993643 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 1999
Decision Date December 28, 1999
Days to Decision 61 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 125d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWJ Device Classification - Class 2, Special Controls

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 27
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K993643.
SEER LIGHT COMPACT DIGITAL HOLTER RECORDER
K021470 · General Electric Medical Systems Information Techn · Nov 2002
H12+HOLTER RECORDER
K021373 · Mortara Instrument, Inc. · Jun 2002
PE 501 PC-ECG MONITOR
K992584 · Nhe Corp. · Jan 2000
DIGITRAKPLUS HOLTER RECORDER
K993617 · Braemar Corp. · Nov 1999
DXP1000 HOLTER RECORDER
K993618 · Braemar Corp. · Nov 1999
TES-20
K992425 · Tes Electrical Electronic Corp. · Oct 1999